{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:43:41Z","timestamp":1781577821766,"version":"3.54.5"},"reference-count":26,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open Access Publication Fund of the University of M\u00fcnster"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: To compare the efficacy and safety of Hydrus\u00ae Microstent and iStent inject\u00ae W implants, in combination with phacoemulsification, for lowering intraocular pressure (IOP) in patients with glaucoma in a real-world clinical setting. Methods: This retrospective, single-center study analyzed medical records of glaucoma patients who underwent either Hydrus\u00ae Microstent or iStent inject\u00ae W implantation combined with cataract surgery at the University Hospital Muenster, Germany. Key outcome measures included absolute and relative IOP reduction, reduction in topical antiglaucoma medication use, overall success rate, and complications. A total of 32 eyes were analyzed, 16 in each treatment group, with a 12-month follow-up. Results: Both groups demonstrated significant postoperative IOP reduction (Hydrus: p &lt; 0.001; iStent inject\u00ae W: p = 0.032). The Hydrus group achieved significantly greater relative IOP reduction compared to the iStent inject\u00ae W group (p = 0.043). The Hydrus group also showed a significant reduction in daily antiglaucoma medication use (p = 0.002), whereas the iStent inject\u00ae W group did not achieve statistical significance in this regard (p = 0.054). The overall success rate was higher in the Hydrus group (38%) than in the iStent inject\u00ae W group (13%), though the difference was not statistically significant (p = 0.102). No device-related complications were observed in either group. Conclusions: The Hydrus\u00ae Microstent demonstrated superior IOP reduction and a more significant reduction in the need for antiglaucoma medications compared to the iStent inject\u00ae W in a real-world setting. These findings support the use of the Hydrus implant as an effective and safe micro-invasive glaucoma surgery (MIGS) option for patients with mild to moderate POAG. Further studies with larger patient populations and long-term follow-up are warranted to confirm the efficacy in patients with PEX and advanced glaucoma.<\/jats:p>","DOI":"10.3390\/diagnostics15040493","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:47:06Z","timestamp":1739850426000},"page":"493","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of the Intraocular Pressure-Lowering Effect of Minimally Invasive Glaucoma Surgery (MIGS) iStent Inject W and Hydrus\u2014The 12-Month Real-Life Data"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5136-5997","authenticated-orcid":false,"given":"Cedric","family":"Weich","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Muenster Medical Center, Domagkstra\u00dfe 15, 48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian Alexander","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Muenster Medical Center, Domagkstra\u00dfe 15, 48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8063-6548","authenticated-orcid":false,"given":"Jens Julian","family":"Storp","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Muenster Medical Center, Domagkstra\u00dfe 15, 48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph-Laurent","family":"Mert\u00e9","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Muenster Medical Center, Domagkstra\u00dfe 15, 48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Eter","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Muenster Medical Center, Domagkstra\u00dfe 15, 48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-8043","authenticated-orcid":false,"given":"Viktoria Constanze","family":"Br\u00fccher","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Muenster Medical Center, Domagkstra\u00dfe 15, 48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0039-6257(05)80042-6","article-title":"Mechanisms of optic nerve damage in primary open angle glaucoma","volume":"39","author":"Fechtner","year":"1994","journal-title":"Surv. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/mja2.50020","article-title":"Current management of glaucoma","volume":"210","author":"Lusthaus","year":"2019","journal-title":"Med. J. Aust."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00347-020-01146-x","article-title":"Glaucoma surgery today","volume":"118","author":"Hoffmann","year":"2021","journal-title":"Ophthalmologe"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s12325-019-00984-9","article-title":"Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study","volume":"36","author":"Hengerer","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40123-021-00424-4","article-title":"Standalone Implantation of 2\u20133 Trabecular Micro-Bypass Stents (iStent inject +\/- iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma","volume":"11","author":"Gravina","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40662-019-0157-y","article-title":"Hydrus microstent implantation for surgical management of glaucoma: A review of design, efficacy and safety","volume":"6","author":"Samet","year":"2019","journal-title":"Eye Vis."},{"key":"ref_9","first-page":"CD012740","article-title":"Ab interno trabecular bypass surgery with Schlemm s canal microstent (Hydrus) for open angle glaucoma","volume":"3","author":"Otarola","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e051496","DOI":"10.1136\/bmjopen-2021-051496","article-title":"Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: Systematic review and network meta-analysis","volume":"12","author":"Hu","year":"2022","journal-title":"BMJ Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","article-title":"A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study","volume":"127","author":"Ahmed","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s40123-023-00819-5","article-title":"Comparative Effectiveness and Safety of Two Different Trabecular MIGS Devices with and Without Ab Interno Canaloplasty in Patients with Primary Open-Angle Glaucoma","volume":"12","author":"Shultz","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamaophthalmol.2021.2351","article-title":"Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma: An Overview of Cochrane Systematic Reviews and Network Meta-analysis","volume":"139","author":"Bicket","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjophthalmol-2023-egsguidelines","article-title":"European Glaucoma Society\u2014A guide on surgical innovation for glaucoma","volume":"107","author":"Stalmans","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Balas, M., and Mathew, D.J. (2023). Minimally Invasive Glaucoma Surgery: A Review of the Literature. Vision, 7.","DOI":"10.3390\/vision7030054"},{"key":"ref_16","unstructured":"Hodapp, E.P., Ramulu, K., and Anderson, D.R. (1993). Clinical Decisions in Glaucoma, Mosby Incorporated."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jcrs.2018.11.005","article-title":"Trabecular microbypass stent implantation in pseudophakic eyes with open-angle glaucoma: Long-term results","volume":"45","author":"Ferguson","year":"2019","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","article-title":"Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm\u2019s Canal Microstent in Combination Cataract and Glaucoma Surgery","volume":"129","author":"Ahmed","year":"2022","journal-title":"Ophthalmology"},{"key":"ref_19","first-page":"51","article-title":"The effect of phacoemulsification and combined phaco\/glaucoma procedures on the intraocular pressure in open-angle glaucoma. A review of the literature","volume":"320","author":"Augustinus","year":"2012","journal-title":"Bull. Soc. Belge. Ophtalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41433-019-0459-2","article-title":"Combined phacoemulsification and microinvasive glaucoma surgery in comparison to phacoemulsification alone for open angle glaucoma","volume":"34","author":"Lee","year":"2020","journal-title":"Eye"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/OPTH.S389406","article-title":"Systematic Literature Review of Clinical, Economic, and Humanistic Outcomes Following Minimally Invasive Glaucoma Surgery or Selective Laser Trabeculoplasty for the Treatment of Open-Angle Glaucoma with or Without Cataract Extraction","volume":"17","author":"Cantor","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/bjo.65.4.264","article-title":"Pigment dispersion syndrome: A clinical study","volume":"65","author":"Scheie","year":"1981","journal-title":"Br. J. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.17219\/acem\/64023","article-title":"Evaluation of the anterior chamber angle in pseudoexfoliation syndrome","volume":"26","author":"Iwanejko","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/IJG.0000000000002475","article-title":"Combined Phacoemulsification and Hydrus Microstent Implantation in Asian Eyes with Moderate-to-Severe Normal Tension Glaucoma\u201412-Month Outcomes","volume":"33","author":"Ang","year":"2024","journal-title":"J. Glaucoma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2147\/OPTH.S465828","article-title":"MIGS in Severe Glaucoma: 12-Month Retrospective Efficacy and Safety of Microinvasive Glaucoma Surgery with Cataract Extraction","volume":"18","author":"Oberfeld","year":"2024","journal-title":"Clin. Ophthalmol."},{"key":"ref_26","unstructured":"Weich, C., Mert\u00e8, R.-L., Eter, N., and Br\u00fccher, V. (2024, January 10\u201313). Vergleich des augeninnendrucksenkenden Effekts von Minimalinvasiver Glaukomchirurgie (MIGS) iStent inject W und Hydrus\u2014Die 12 Monats\u2014Real Life Daten. Proceedings of the DOG, Berlin, Germany."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/4\/493\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:36:37Z","timestamp":1760027797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/4\/493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["diagnostics15040493"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15040493","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}